Rani Therapeutics Holdings Inc (RANI) Live Share Price, Invest From India

Rani Therapeutics Holdings Inc Stock Performance

as on April 25, 2026 at 2:12 am IST

Day's High
$0.88
Day's Price Range
$0.95
$0.88
7.95%
Upside
52 Week's Low
52 Week's High
$0.39
52-Week Price Range
$3.87
$0.88
56.02%
Downside
339.77%
Upside

Rani Therapeutics Holdings Inc share price movements today

Previous Close: $0.92
Open: $0.95
Volume: 629.0K
Day's Low - High: $0.88 - $0.95
52 Week Low - High: $0.39 - $3.87

Rani Therapeutics Holdings Inc Historical Returns

1 Month Return: -13.63 %
3 Month Return: -34.14 %
1 Year Return: -18.26 %
3 Year Return: -80.52 %
5 Year Return: 0 %

Rani Therapeutics Holdings Inc Stock Fundamentals & Key Indicators

Check Rani Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$118.7M

EPS (TTM)

-0.194

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-37.4M

Revenue (TTM)

1.6M

Profit Margin

0.00%

Return On Equity TTM

-181.98%

Rani Therapeutics Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rani Therapeutics Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Rani Therapeutics Holdings Inc	BUY	$118.7M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.4B	129.51%	133.3	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.3B	99.68%	28.57	32.94%
BeiGene, Ltd.	NA	$33.3B	NA	121.87	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	56.77%	17.99	31.41%

Stock Returns calculator for Rani Therapeutics Holdings Inc Stock including INR - Dollar returns

The Rani Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Rani Therapeutics Holdings Inc investment value today

Current value as on today

₹86,769

Returns

-₹13,231

(-13.23%)

Returns from Rani Therapeutics Holdings Inc Stock

-₹21,429 (-21.43%)

Dollar Impact

₹8,198 (+8.2%)

Analyst Recommendation on Rani Therapeutics Holdings Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Rani Therapeutics Holdings Inc. Average target price of $7.4

Rani Therapeutics Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Rani Therapeutics Holdings Inc.

What analysts predicted

88.11%UPSIDE

Target Price

$7.4

Current Price

$0.88

Analyzed by

13 Analysts

Target

$7.40

Rani Therapeutics Holdings Inc target price $7.4, a slight upside of 88.11% compared to current price of $0.88. According to 13 analysts rating.

Rani Therapeutics Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Rani Therapeutics Holdings Inc Stock has increased by 127% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 25, 2026 to April 24, 2026

Change:127% versus previous 30 day period

Rani Therapeutics Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	2	-	-	-	1	0	-	-	1
Gross Profit	0	2	0	0	0	1	0	0	0	1
Operating Income	-17	-13	-14	-12	-11	-14	-12	-10	-7	-8
EBITDA	-16	-12	-13	-11	-11	-14	-11	-10	-6	-8
Interest Expense	1	1	1	1	1	1	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-18	-14	-14	-13	-12	-15	-12	-11	-7	-9
Income Tax Expense	-9	-6	-7	-6	-	-	-	-	-	-
Net Income	-9	-7	-7	-6	-6	-8	-7	-6	-5	-10
Net Profit Margin	0.00%	-258.11%	0.00%	0.00%	0.00%	-870.33%	-4223.26%	0.00%	0.00%	-705.41%

Rani Therapeutics Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	2	-	-	1	1
Gross Profit	0	0	2	-1	0	1	0
Operating Income	-27	-16	-51	-63	-66	-53	-38
EBITDA	-26	-15	-52	-61	-65	-50	-37
Interest Expense	0	0	0	1	5	5	2
Depreciation	0	0	0	0	0	1	0
Income Before Tax	-26	-16	-53	-63	-67	-30	-40
Income Tax Expense	0	0	0	0	-33	26	-
Net Income	-26	-16	-8	-30	-33	-30	-29
Net Profit Margin	-2716.75%	-3615.37%	-306.62%	0.00%	0.00%	-2920.04%	-1817.09%

Rani Therapeutics Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-7	-7	-6	-12	-15	-7	-6	-7	-3
Operating Cash Flow	-12	-9	-9	-8	-8	-8	-5	-5	0
Investing Cash Flow	13	10	6	0	2	18	5	0	-30
Financing Cash Flow	0	0	0	7	5	-3	0	-1	44
Change in Cash	0	1	-2	0	0	6	0	-6	14

Rani Therapeutics Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-8	-63	-33	-56	-29
Operating Cash Flow	-14	-32	-46	-51	-35	-18
Investing Cash Flow	-1	0	-72	29	19	-7
Financing Cash Flow	72	77	29	0	13	40
Change in Cash	56	44	-89	-21	-2	14

Global Institutional Holdings in Rani Therapeutics Holdings Inc

Funds	Holdings
Samsara BioCapital, LLC	8.52%
Awm Investment Company Inc	6.52%
683 Capital Management LLC	0.49%
Nan Fung Group Holdings Ltd	0.51%
Insigneo Advisory Services LLC	0.1%

See all

Insights on Rani Therapeutics Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.2% return, outperforming this stock by 133.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.3% return, outperforming this stock by 47.6%
NEGATIVE IMPACT
Price Dip
In the last 1 month, RANI stock has moved down by -13.6%

About Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.

Organisation	Rani Therapeutics Holdings Inc
Headquarters	2051 Ringwood Avenue, San Jose, CA, United States, 95131
Industry	Biotechnology
CEO	Mr. Talat Imran
E-voting on shares	Click here to vote

Key Management of Rani Therapeutics Holdings Inc

Name	Title
Mr. Mir A. Imran	Executive Chairman
Mr. Talat Imran	CEO & Director
Mr. Svai S. Sanford	Chief Financial Officer
Ms. Kate McKinley M.B.A.	Chief Business Officer
Dr. Mir Hashim	Chief Scientific Officer
Ms. Bella Vazquez	Senior Vice President of People & Administrative Services
Mr. Jesper Hoeiland M.Sc.	Head of Strategy
Ms. Arvinder Dhalla	Vice President of Clinical Development

FAQs

What is Rani Therapeutics Holdings Inc share price today?

Rani Therapeutics Holdings Inc share price today is $0.88 as on April 24, 2026 at 8:42 pm IST. Rani Therapeutics Holdings Inc share today touched a day high of $0.95 and a low of $0.88.

What is the 52 week high and 52 week low for Rani Therapeutics Holdings Inc share?

Rani Therapeutics Holdings Inc share touched a 52 week high of $3.87 on October 22, 2025 and a 52 week low of $0.39 on July 15, 2025. Rani Therapeutics Holdings Inc stock price today i.e. April 24, 2026 at 8:42 pm IST is trending at $0.88,which is 77.26% down from its 52 week high and 127.39% up from its 52 week low.

What is Rani Therapeutics Holdings Inc's market capitalisation today?

Rani Therapeutics Holdings Inc market capitalisation is $0.00T as on April 24, 2026 at 8:42 pm IST.

How to invest in Rani Therapeutics Holdings Inc Stock (RANI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rani Therapeutics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rani Therapeutics Holdings Inc Shares that will get you 1.7045 shares as per Rani Therapeutics Holdings Inc share price of $0.88 per share as on April 24, 2026 at 8:42 pm IST.

What is the minimum amount required to buy Rani Therapeutics Holdings Inc Stock (RANI) from India?

Indian investors can start investing in Rani Therapeutics Holdings Inc (RANI) shares with as little as ₹94.228 or $1 (as of April 24, 2026 at 8:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Rani Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on April 24, 2026 at 8:44 pm IST). Based on Rani Therapeutics Holdings Inc share’s latest price of $0.88 as on April 24, 2026 at 8:42 pm IST, you will get 11.3636 shares of Rani Therapeutics Holdings Inc. Learn more about fractional shares .